Lipoid Congenital Adrenal Hyperplasia (CAH): Patient Report and a Mini-Review

Abstract

Get full access to this article

View all access options for this article.

References

1. Miller WL . Lessons from congenital lipoid adrenal hyperplasia. Curr Opinion Endocrinol Diabetes. 1998;5:155-161.

2. Lin D , Sugawara T , StraussJF III , et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 1995;267: 1828-1831.

3. Nakae J , Tajima T , Sugawara T , et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet. 1997;6:571-576.

4. Lee MM , Donahoe PK , Hasegawa T , et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab. 1996;81:571-576.

5. Prader A , Gurtner HP . Das syndrom des Pseudohermaphroditismus masculine bei kongenitaler Nebennierenridenhyperplasie ohne Androgenuberxproduktion (adrenaler Pseudohermaphroditismus masculinus). Helv Paediatr Acta. 1955;10:397-412.

6. Prader A , Siebenmann RE . Nebennierensuffizienz bie kongenitaler Lipoidhyperplasie der Nebennieren. Helv PaediatrActa. 1957;12:569-595.

7. Prader A , Anders CJPA . Zur Genetik der kongenitalen Lipoidhyperplasie der Nebennieren. Helv Paediatr Acta. 1962;7:285-289.

8. Miller W . Congenital lipoid adrenal hyperplasia: the human gene knockout of the steroidogenic acute regulatory protein. J Mol Endocrinol. 1997;19:227-240.

9. Shimizu K , Hayano M , Gut M , Dorfman RI . The transformation of 20α-hydroxycholesterol to isocaproic acid and C21 steroids. J Biol Chem. 1961;236:695-699.

10.

10. Degenhard HJ , Visser KHA , Boon H , O'Doherty NJD . Evidence for deficiency of 20a, cholesterol hydroxylase activity in adrenal tissue of a patient with lipoid adrenal hyperplasia. Acta Endocrinol. 1972;71:512-518.

11.

11. Koizumi S , Kyoya S , Miyawaki T , et al. Cholesterol side-chain cleavage enzyme activity and cytochrome P450 content in adrenal mitochondria of a patient with congenital lipoid adrenal hyperplasia (Prader disease). Clin Chim Acta. 1977;77:301-306.

12.

12. Lin D , Gitelman SE , Saenger P , Miller WL . Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. Clin Invest. 1991;88:1955-1962.

13.

13. Bose HS , Sugaware T , Strauss JF III , Miller WL . The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med. 1996;335:1870-1878.

14.

14. Stocco DM . An update on the mechanism of action of the steroidogenic acute regulatory (stAR) protein. Exp Clin Endocrinol Diabetes. 1999;107:229-235.

15.

15. Conn PM , (ed). The steroidogenic acute regulatory protein (StAR): a window into the complexities of intracellular cholesterol trafficking. Recent Progress in Hormone Research. Proceedings of the 1998 conference of Recent Progress in Hormone Research, 1998, Washington. Maryland: The Endocrine Society, 2000.

16.

16. Bose H , Pescovitz OH , Miller WL . Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia caused by a homozygous frame-shift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab. 1997;82:1511-1515.